Our mission is to ensure that emotion artificial intelligence benefits all of humanity. At OpenEmo AI, we specialize in innovative diagnostics that identify emotional biomarkers linked to pain and disease risk. Our patent-pending technology allows for a deeper understanding of how emotions impact physical health. By detecting emotional signatures, we can provide insights that traditional diagnostics may overlook, especially as it relates to the over or under use of medication. Our goal is to empower individuals with knowledge that can lead to better health outcomes. Join us in revolutionizing the way we approach health and wellnes,
Our pioneering patent pending AI technology identifies emotional patterns linked to pain, medication and disease risk, enabling both patients and healthcare providers to 1) make more informed decisions, 2) provide evidenced-based healthcare data and 3) reduced hospital readmission costs.
